119 related articles for article (PubMed ID: 7251472)
21. [Basic study and clinical application of acetyl-spiramycin in surgical field].
Shibata K; Kuno K; Imazu I; Ito T; Inugai A
J Antibiot B; 1966 Jun; 19(3):200-5. PubMed ID: 5298422
[No Abstract] [Full Text] [Related]
22. Efficacy trials in turkey poults with tylosin tartrate against Mycoplasma gallisepticum and Mycoplasma meleagridis.
Wise DR; Fuller MK
Res Vet Sci; 1975 Nov; 19(3):338-9. PubMed ID: 1215688
[TBL] [Abstract][Full Text] [Related]
23. Macrolide antibiotics M-4365 produced by Micromonospora. IV. Antimycoplasmal activity of antibiotic M-4365 G2 (de-epoxy rosamicin).
Onta T; Maezawa I; Kinumaki A; Ohshima S; Yamaguchi T
J Antibiot (Tokyo); 1981 Jun; 34(6):719-26. PubMed ID: 7275854
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of tylosin-related macrolides modified at the aldehyde function: a new series of orally effective antibiotics.
Kirst HA; Toth JE; Debono M; Willard KE; Truedell BA; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
J Med Chem; 1988 Aug; 31(8):1631-41. PubMed ID: 3398001
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic efficacy of 3-acetyl-4''-isovaleryl tylosin in a Mycoplasma gallisepticum-induced airsacculitis infection.
Skelly BJ; Andersen D; Pruss M; Pellegrino R
Avian Dis; 1986; 30(3):505-9. PubMed ID: 3767811
[TBL] [Abstract][Full Text] [Related]
26. Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivatives.
Cacciapuoti AF; Loebenberg D; Moss EL; Menzel FW; Rudeen JA; Naples LR; Cramer CL; Hare RS; Mallams AK; Miller GH
J Antibiot (Tokyo); 1990 Sep; 43(9):1131-6. PubMed ID: 2145254
[TBL] [Abstract][Full Text] [Related]
27. [Studies on josamycin. 3. (1) Bacteriological studies. (2) Protective effect against infections due to pathogenic bacteria. (3) Absorption, excretion, distribution in organs and in vivo activities].
Osono T; Yano K; Mitamoto F; Watanabe S; Ishida H
Jpn J Antibiot; 1969 Apr; 22(2):159-72. PubMed ID: 4389777
[No Abstract] [Full Text] [Related]
28. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.
Ose EE
J Antibiot (Tokyo); 1987 Feb; 40(2):190-4. PubMed ID: 3570967
[TBL] [Abstract][Full Text] [Related]
29. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
Omura S; Miyano K; Matsubara H; Nakagawa A
J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
[TBL] [Abstract][Full Text] [Related]
30. [Spiramycin derivatives. 2].
Takahira H
Jpn J Antibiot; 1970 Aug; 23(4):429-33. PubMed ID: 5312795
[No Abstract] [Full Text] [Related]
31. [Basic and clinical results with acetyl spiramycin in surgery].
Ishii T; Shimamoto M; Yokoyama Y; Hiraga S; Kishi A
J Antibiot B; 1966 Dec; 19(6):432-7. PubMed ID: 5298389
[No Abstract] [Full Text] [Related]
32. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives.
Debono M; Willard KE; Kirst HA; Wind JA; Crouse GD; Tao EV; Vicenzi JT; Counter FT; Ott JL; Ose EE
J Antibiot (Tokyo); 1989 Aug; 42(8):1253-67. PubMed ID: 2668243
[TBL] [Abstract][Full Text] [Related]
33. [Antimycoplasmal activities of ofloxacin and commonly used antimicrobial agents on Mycoplasma gallisepticum].
Takahashi I; Yoshida T
Jpn J Antibiot; 1989 May; 42(5):1166-72. PubMed ID: 2526260
[TBL] [Abstract][Full Text] [Related]
34. A review of the medical considerations of the use of tylosin and other macrolide antibiotics as additives in animal feeds.
Knothe H
Infection; 1977; 5(3):183-7. PubMed ID: 334674
[TBL] [Abstract][Full Text] [Related]
35. [Studies of isolated organisms from otorhinolaryngological infections and their susceptibilities to macrolide antibiotics].
Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Sugita R; Fujimaki Y; Sanbe B; Ogura S
Jpn J Antibiot; 1985 May; 38(5):1355-67. PubMed ID: 3930804
[TBL] [Abstract][Full Text] [Related]
36. Chemical modification of tylosin. Thioether derivatives of tylosin and demycarosyltylosin.
Omura S; Matsubara H; Tsuzuki K; Nakagawa A
J Antibiot (Tokyo); 1984 Sep; 37(9):1007-15. PubMed ID: 6501102
[TBL] [Abstract][Full Text] [Related]
37. Physico-chemical properties of new acyl derivatives of tylosin produced by microbial transformation.
Okamoto R; Fukumoto T; Nomura H; Kiyoshima K; Nakamura K; Takamatsu A; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1300-8. PubMed ID: 7251471
[TBL] [Abstract][Full Text] [Related]
38. Rarity of gene transfer between animal and human isolates of Staphylococcus aureus in vitro.
Lacey RW
J Gen Microbiol; 1980 Aug; 119(2):437-42. PubMed ID: 6453205
[TBL] [Abstract][Full Text] [Related]
39. Rarity of tylosin resistance in human pathogenic bacteria.
Lacey RW
Vet Rec; 1988 Apr; 122(18):438-9. PubMed ID: 3293307
[TBL] [Abstract][Full Text] [Related]
40. [Clinical results of 9,3"-diacetylmidecamycin in the field of pediatrics (author's transl)].
Shinozaki T; Meguro H; Koike Y; Hashira S; Fujii R
Jpn J Antibiot; 1982 Jan; 35(1):251-60. PubMed ID: 6978413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
